All about the Oncotype DX test and how it differs from Tumor DNA Sequencing

Precision Oncology specialist, Alex Rolland, discusses the Oncotype DX test: how it works, what it actually shows you, and how it differs from tumor DNA sequencing. He also explains why so many patients are confused about this test in general.

Watch this video to learn:

  • – What the Oncotype DX test is and how it works
  • – How to understand the scoring for pre-menopause vs. post-menopause
  • – Flowchart to help explain the different results
  • – Exploring the TAILORx Trial
  • – Which patients are able to avoid chemo
  • – Which patients are likely to benefit from chemo
  • – Disadvantages of the Oncotype DX test
  • – How this test differs from tumor DNA sequencing
  • – How patients can get the information and support they need now

What Breast Cancer Patients Need to Know About the Oncotype DX Test

Alex also explains the results of the TAILORx Trial, which showed some crucial – and potentially surprising – information that all breast cancer patients should know about. 

He is joined by Precision Oncology Advocate and CTOAM cofounder, Michelle Morand. Together they share next steps that breast cancer patients can take to identify the most effective treatment for them. 

Want More Support?

Learn more with our free resources

Join our free online support group

Sign up here: “Cancer – Just the Facts” online Advocacy & Support Group

Precision Cancer Medicine Advocacy Specialist, Michelle Morand, hosts this unique online support program for cancer patients and their loved ones. Our goal is to empower all patients to understand what is possible in cancer treatment today – and how to access it, for as little cost as possible and through their current doctor.

Join us for regular live Zoom calls where Michelle provides advocacy coaching and support. We also hold monthly live Zoom Office Hours with Alex Rolland, where you can ask Alex anything about your specific cancer case and he will share his recommendations and feedback.

Published by on June 15, 2024